Docusign Inc. $DOCU Stock Holdings Lifted by Greenwich Wealth Management LLC

Greenwich Wealth Management LLC boosted its position in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) by 30.0% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 120,835 shares of the company’s stock after buying an additional 27,855 shares during the quarter. Greenwich Wealth Management LLC’s holdings in Docusign were worth $5,367,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in DOCU. QRG Capital Management Inc. increased its position in shares of Docusign by 31.2% in the second quarter. QRG Capital Management Inc. now owns 11,132 shares of the company’s stock valued at $495,000 after acquiring an additional 2,645 shares during the period. Envestnet Portfolio Solutions Inc. increased its position in Docusign by 3.1% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 11,867 shares of the company’s stock valued at $527,000 after purchasing an additional 356 shares during the period. Integrated Wealth Concepts LLC raised its holdings in Docusign by 2.0% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 14,359 shares of the company’s stock worth $638,000 after purchasing an additional 277 shares in the last quarter. NewEdge Advisors LLC lifted its position in shares of Docusign by 29.8% in the 2nd quarter. NewEdge Advisors LLC now owns 14,311 shares of the company’s stock worth $636,000 after purchasing an additional 3,287 shares during the period. Finally, IFP Advisors Inc boosted its stake in shares of Docusign by 38.9% during the 2nd quarter. IFP Advisors Inc now owns 3,923 shares of the company’s stock valued at $174,000 after purchasing an additional 1,098 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Zacks raised several long-term earnings forecasts. FY2027 EPS was increased to $1.96 from $1.69, FY2028 EPS to $2.07 from $1.76, and FY2029 EPS to $1.95 from $1.35. Zacks also lifted estimates for Q1 2028, Q2 2028, Q3 2028 and Q2 2029, signaling improved expectations for Docusign’s profitability. Docusign Stock Earnings Estimates Lifted by Zacks Research
  • Positive Sentiment: Zacks identified Docusign as a long-term momentum stock. Its style-score analysis highlights the company’s favorable momentum characteristics, which may support investor interest if earnings growth continues. Why DocuSign is a Top Momentum Stock for the Long-Term
  • Neutral Sentiment: The revisions were mixed. Zacks raised its Q2 2029 EPS estimate to $0.67 from $0.21, but lowered Q1 2029 EPS to $0.66 from $0.73 and Q4 2028 EPS to $0.57 from $0.62. The conflicting changes may have limited the immediate bullish impact.
  • Negative Sentiment: Most of the positive revisions are distant. Investors may be focusing more on current and upcoming results than forecasts extending through FY2029. Docusign’s prior quarter showed solid execution—$1.16 EPS versus a $1.09 estimate and 9.4% year-over-year revenue growth—but the stock’s elevated valuation leaves less room for disappointment.

Insiders Place Their Bets

In other news, insider James Shaughnessy sold 12,000 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $546,480.00. Following the completion of the sale, the insider directly owned 52,815 shares of the company’s stock, valued at $2,405,195.10. This represents a 18.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Peter Solvik sold 46,000 shares of the firm’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $65.24, for a total transaction of $3,001,040.00. Following the sale, the director owned 49,558 shares in the company, valued at $3,233,163.92. The trade was a 48.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 182,568 shares of company stock valued at $10,892,550. Insiders own 0.59% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on DOCU shares. Morgan Stanley lifted their price objective on Docusign from $69.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, September 4th. Citigroup lifted their price target on Docusign from $54.00 to $72.00 and gave the stock a “neutral” rating in a research report on Friday, September 4th. BTIG Research upped their price target on shares of Docusign from $60.00 to $75.00 and gave the stock a “buy” rating in a research note on Wednesday, September 2nd. Wells Fargo & Company increased their price objective on shares of Docusign from $55.00 to $60.00 and gave the company an “equal weight” rating in a research report on Friday, September 4th. Finally, UBS Group raised their price objective on shares of Docusign from $54.00 to $70.00 and gave the company a “neutral” rating in a research note on Friday, September 4th. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $67.33.

Check Out Our Latest Report on DOCU

Docusign Price Performance

Shares of DOCU traded down $0.27 on Tuesday, reaching $66.71. The company’s stock had a trading volume of 581,344 shares, compared to its average volume of 4,059,076. The stock’s 50 day simple moving average is $61.99 and its two-hundred day simple moving average is $52.43. The stock has a market capitalization of $12.47 billion, a P/E ratio of 40.75, a PEG ratio of 2.54 and a beta of 0.90. Docusign Inc. has a 12-month low of $40.16 and a 12-month high of $81.88.

Docusign (NASDAQ:DOCU – Get Free Report) last released its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.07. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The business had revenue of $875.75 million for the quarter, compared to the consensus estimate of $867.22 million. During the same period last year, the firm earned $0.30 earnings per share. The company’s quarterly revenue was up 9.4% on a year-over-year basis. Analysts expect that Docusign Inc. will post 2.1 earnings per share for the current year.

About Docusign

(Free Report)

DocuSign, Inc is a provider of digital agreement management and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping businesses replace paper-based contracting processes with digital workflows.

The company’s products and services include DocuSign eSignature, which supports electronic signing and authentication, as well as tools for contract lifecycle management, agreement preparation, identity verification, notarial services and workflow automation.

Featured Stories

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.